Oncolytics Closes Offering of 8M Shares at $4/Share for Gross Proceeds of $32M
Oncolytics Biotech Inc. (NASDAQ: ONCY) announced today that it has closed its previously announced underwritten public offering of 8.0 million common shares, at a public offering price of US$4.00 per common share. The aggregate gross proceeds from the offering, before deducting underwriting discounts and commissions and offering expenses payable by Oncolytics, were approximately US$32.0 million.
© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.